Jun 7, 2021 · The new drug, Wegovy, has proven to be safer and more effective than existing weight loss drugs, says MSN. Wegovy is approved and intended for obese and overweight adults, reported Science Alert. The drug is expected to hit consumer markets in the U.S. very soon, according to MSN. The price has not yet been confirmed but is expected to cost ... There are other promising new weight loss drugs in the works. Retatrutide, oral semaglutide, and more are in phase 3 clinical trials. A handful are enrolled in phase 2 trials. Several medications are already FDA-approved for weight loss. Wegovy (semaglutide), Saxenda (liraglutide), and Contrave (naltrexone / bupropion) are common examples.Dec 6, 2021 · "This is a start of a new era of effective treatments for obesity," he added. The future of anti-obesity drugs. In June, FDA approved semaglutide as a treatment for chronic weight management in obese or overweight adults—the first drug approved for such use since 2014. Currently, there are six FDA-approved medications for the long-term ... A potential 'game changer' drug for weight loss and obesity was just approved by the FDA. The FDA approved semaglutide, a drug designed to treat type 2 diabetes, to help people lose weight ... FDA approved Qsymia in July 2012 for chronic weight management in adults with an initial BMI of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one ...Jan 9, 2023 · Wegovy is now the first once-weekly weight loss drug approved for adolescents. A significant milestone to bring in the new year, the FDA approved Wegovy (semaglutide) on Dec. 23, 2022, for teens ages 12 and up who have a BMI at or above the 95 th percentile for their age and sex. The drug was originally approved for adults with obesity in June ... Mar 28, 2022 · Saxenda. How it works: Saxenda (liraglutide), is an injectable medication that reduces food intake by decreasing appetite and increasing feelings of fullness. Effectiveness: A 2016 review found that, after one year, the average user lost between 8.9 pounds and 13.3 pounds. Jun 20, 2023 · 6/15/2023. To treat diffuse large B-cell lymphoma, not otherwise specified, or large B-cell lymphoma arising from follicular lymphoma after two or more lines of systemic therapy. 22. Inpefa ... The FDA on Friday approved a new weight-loss drug, Wegovy, for people who are either obese or overweight and have at least one weight-related medical problem.Apr 4, 2023 · The weight-loss drug that it contains, semaglutide, is a potent treatment for obesity, and Hollywood and TikTok celebrities have turned it into a sensation. ... which was approved by the FDA in ... Jun 20, 2023 · 6/15/2023. To treat diffuse large B-cell lymphoma, not otherwise specified, or large B-cell lymphoma arising from follicular lymphoma after two or more lines of systemic therapy. 22. Inpefa ... And yes, these drugs often come with the bonus side effect of weight loss. With most GLP-1 drugs, however, weight loss tends to be modest — most people lose only 6 to 9 pounds. Those who take 2.4 mg of semaglutide (Wegovy) often lose far more. If your starting weight is 200 pounds and the drug enables you to drop 15 percent, you'll lose 30 ...Obesity specialist Dr. Spencer Nadolsky shares what new weight-loss medications are on the horizon, and explains common misconceptions about these drugs. ... using an FDA-approved weight loss drug ...FDA approves weight-management drug Qsymia. Medications Target Long-Term Weight Control. FDA approves Belviq to treat some overweight or obese adults. Fen-Phen Safety Update Information. Today, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one...Lilly presented results on an oral weight loss drug at the conference on Friday. Participants taking the drug, called orforglipron, lost an average of 9.4% to 14.7% of their body weight, depending ...I n a rare move, the Food and Drug Administration (FDA) has approved a novel prescription device meant to help with weight management. The product, called Plenity and developed by Gelesis, has ...The new drug, Wegovy, has proven to be safer and more effective than existing weight loss drugs, says MSN. Wegovy is approved and intended for obese and overweight adults, reported Science Alert. The drug is expected to hit consumer markets in the U.S. very soon, according to MSN. The price has not yet been confirmed but is expected to cost ...High Demand, Low Supply Postpones 'Miracle' FDA-Approved Weight Loss Drug to Mid-2022. The wait for a new weight loss drug will take a bit longer than expected. Wegovy, a drug manufactured by Novo ...April 27, 20236:16 AM ET Allison Aubrey Enlarge this image Eli Lilly is seeking FDA approval for tirzepatide for chronic weight management. The drug could be approved by the end of the...Jan 3, 2023 · Diabetes drug Tirzepatide, which is shown to be more effective than Wegovy and Ozempic, is likely to be approved by the Food and Drug Administration for weight loss in 2023 and is expected to be ... Obesity specialist Dr. Spencer Nadolsky shares what new weight-loss medications are on the horizon, and explains common misconceptions about these drugs. ... using an FDA-approved weight loss drug ...Apr 4, 2023 · The weight-loss drug that it contains, semaglutide, is a potent treatment for obesity, and Hollywood and TikTok celebrities have turned it into a sensation. ... which was approved by the FDA in ... Jun 5, 2021 · Few drugs are approved in the United States specifically for weight loss. They include orlistat, sold under the brand name Xenical, which helps reduce the amount of fat the body absorbs; Qsymia, a ... The Food and Drug Administration (FDA) on Friday approved a weight loss drug for overweight or obese adults, marking the first such authorization since 2014. The drug, Wegovy, is an under-the-skin ...Jul 17, 2012 · July 17, 2012, 12:15 PM. July 17, 2012 -- The U.S. Food and Drug Administration has approved the diet drug Qsymia, the agency's latest move to give doctors and their patients more tools to fight ... Apr 9, 2020 · Weight-loss drug Belviq recalled. April 9, 2020. By Florencia Halperin, MD, Contributor. In February, the manufacturer of the weight-loss medication lorcaserin (Belviq, Belviq XR) voluntarily withdrew the drug from the US market at the request of the FDA. This was a result of emerging data showing that people who had taken the drug as part of a ... Nov 10, 2022 · The FDA last year approved semaglutide, which was developed initially as a treatment for type 2 diabetes, for weight loss in adults. But researchers wanted to know if the drug, which targets areas ... Nov 7, 2022 · The FDA has approved the drug Wegovy (semaglutide) treat obesity in children. The news comes after a study found that the weight loss drug may help adolescents significantly reduce BMI. It works ... Jun 27, 2023 · A separate trial is looking at retatrutide for patients with Type 2 diabetes. After 24 weeks, patients taking the highest dose — 12 milligrams — lost, on average, 17.5% of their body weight ... A 'game-changer' weight-loss drug was approved in 2021. Demand was so high that there were shortages within months. Semaglutide, a weight-loss drug, showed promise for treating obesity in recent research. Demand quickly exceeded supply after the FDA in June approved once-weekly semaglutide injections. However, some experts worry that we don't ...Jun 27, 2012 · June 27, 2012. 0. WASHINGTON (AP) -- The Food and Drug Administration has approved Arena Pharmaceutical's anti-obesity pill Belviq, the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade. Despite only achieving modest weight loss in clinical studies, the drug appeared safe enough to win the FDA's ... Gelesis100 (Plenity), just approved by the Food and Drug Administration in April and expected to come on the market later this year, is an exciting recent innovation in weight management. Although Plenity comes in capsule form, it is actually a weight loss device, not a medication. The capsules are filled with hydrogel particles.Feb 10, 2021 · A new anti-obesity medication was shown to be almost twice as effective at helping individuals lose weight than some of the current weight loss drugs on the market, a new study found. ‘By far the most effective drug intervention we have seen for weight management’ Jan 3, 2023 · Diabetes drug Tirzepatide, which is shown to be more effective than Wegovy and Ozempic, is likely to be approved by the Food and Drug Administration for weight loss in 2023 and is expected to be ... NEW YORK (CBSNewYork) - A powerful new tool in the battle of the bulge has just been approved by the FDA. The new capsule is swallowed like a pill, but it's not a drug, it's a gel to make people ...The table below lists prescription drugs approved by the FDA for weight loss. The FDA has ...December 24, 2014 / 3:12 PM / HealthDay. A new, injectable weight-loss drug has been approved by the U.S. Food and Drug Administration. The agency on Tuesday approved Saxenda (liraglutide) for ...A new drug called retatrutide reduced body weight in study participants by up to 24%, according to mid-stage trial data shared by drugmaker Eli Lilly last month. In a small group study, Lilly also showed that retatrutide resolved liver fat in 9 out of 10 participants. There is currently no FDA-approved treatment for fatty liver disease.Apr 5, 2023 · The FDA approved Wegovy in June of 2021, marking the first time since 2014 that federal health authorities had given the green light to a new weight loss drug. (Low Wong’s views do not represent those of the FDA or the FDA Endocrinologic and Metabolic Drugs Advisory Committee .) Jan 9, 2023 · Wegovy is now the first once-weekly weight loss drug approved for adolescents. A significant milestone to bring in the new year, the FDA approved Wegovy (semaglutide) on Dec. 23, 2022, for teens ages 12 and up who have a BMI at or above the 95 th percentile for their age and sex. The drug was originally approved for adults with obesity in June ... The company made the prediction on the timing of FDA approval as it announced top-line results of a Phase 3 study showing a nearly 16% overall weight loss over a 17-month period among people who ...And yes, these drugs often come with the bonus side effect of weight loss. With most GLP-1 drugs, however, weight loss tends to be modest — most people lose only 6 to 9 pounds. Those who take 2.4 mg of semaglutide (Wegovy) often lose far more. If your starting weight is 200 pounds and the drug enables you to drop 15 percent, you'll lose 30 ...There are other promising new weight loss drugs in the works. Retatrutide, oral semaglutide, and more are in phase 3 clinical trials. A handful are enrolled in phase 2 trials. Several medications are already FDA-approved for weight loss. Wegovy (semaglutide), Saxenda (liraglutide), and Contrave (naltrexone / bupropion) are common examples.The Food and Drug Administration (FDA) issued a rare approval for a new weight loss device this week. Plenity, created by Boston biotech company Gelesis, is a hydrogel capsule made with a ...Jan 7, 2014 · FDA Approved: Yes (First approved September 10, 2014) Brand name: Contrave. Generic name: bupropion and naltrexone. Dosage form: Tablets. Company: Orexigen Therapeutics, Inc. Treatment for: Weight Loss (Obesity/Overweight) Contrave (bupropion/naltrexone) is an aminoketone antidepressant and opioid antagonist combination indicated as an adjunct ... Apr 27, 2023 · Eli Lilly seeks FDA approval for weight loss drug tirzepatide 01:57. As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare ... May 20, 2022 · A new prescription medication is dominating a weight loss market crowded with pills, powders, cleanses, juices, and more. In June of 2021, the FDA approved Wegovy (semaglutide), a weekly injectible. Apr 27, 2023 · Eli Lilly seeks FDA approval for weight loss drug tirzepatide 01:57. As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare ... Sep 10, 2021 · On June 4, 2021, the FDA announced the long-anticipated approval of Wegovy, an injectable medication taken once per week for weight management.. Wegovy received significant media attention in the months preceding approval, with a New York Times article declaring it a "game changer," MedPage Today reporting its "unprecedented results," and the BBC announcing it could mark a "new era" in ... In the 1960s, FDA-approved weight-loss drugs were all derivatives of amphetamine, which suppresses appetite. ... Steve Johnson is one of many Americans interested in a new weight-loss drug called ...Nov 10, 2022 · The FDA last year approved semaglutide, which was developed initially as a treatment for type 2 diabetes, for weight loss in adults. But researchers wanted to know if the drug, which targets areas ... Jun 10, 2022 · It was, however, approved for the treatment of type 2 diabetes. The drug trial’s sponsor, Eli Lilly, is working with the FDA on a timeline for approval. Another weight-loss medication is called semaglutide (it’s available by prescription under the brand name Wegovy® ), and it is given once a week by self-injection under the skin. It ... And yes, these drugs often come with the bonus side effect of weight loss. With most GLP-1 drugs, however, weight loss tends to be modest — most people lose only 6 to 9 pounds. Those who take 2.4 mg of semaglutide (Wegovy) often lose far more. If your starting weight is 200 pounds and the drug enables you to drop 15 percent, you'll lose 30 ...Jun 26, 2023 · Eli Lilly’s Mounjaro, cleared for type 2 diabetes and awaiting FDA approval for weight loss, targets both GLP-1 and a hormone called GIP, and has produced weight loss of 21 to 23%. liraglutide, 3 mg. phentermine-topiramate extended-release (ER) naltrexone-bupropion ER. They noted that, when used alongside lifestyle interventions, each of the drugs was linked to a total body ...A new drug called retatrutide reduced body weight in study participants by up to 24%, according to mid-stage trial data shared by drugmaker Eli Lilly last month. In a small group study, Lilly also showed that retatrutide resolved liver fat in 9 out of 10 participants. There is currently no FDA-approved treatment for fatty liver disease.Oct 17, 2021 · In the 1960s, FDA-approved weight-loss drugs were all derivatives of amphetamine, which suppresses appetite. ... Steve Johnson is one of many Americans interested in a new weight-loss drug called ... Jun 17, 2022 · By Simon On June 17, 2022. Eli Lilly’s new drug named, Mounjaro, is currently trending as it was recently approved by the FDA. Reports suggest that the people lost 50 pounds on average with a proper diet and increased physical activity during its trial phase. It costs around $974.33 for four weekly doses and many people believe its price is ... A 'game-changer' weight-loss drug was approved in 2021. Demand was so high that there were shortages within months. Semaglutide, a weight-loss drug, showed promise for treating obesity in recent research. Demand quickly exceeded supply after the FDA in June approved once-weekly semaglutide injections. However, some experts worry that we don't ... A 'game-changer' weight-loss drug was approved in 2021. Demand was so high that there were shortages within months. Semaglutide, a weight-loss drug, showed promise for treating obesity in recent research. Demand quickly exceeded supply after the FDA in June approved once-weekly semaglutide injections. However, some experts worry that we don't ... Made by Eli Lilly, the drug is already approved by the FDA to treat diabetes under the name Mounjaro. However, taken in higher doses it has been shown to aid weight loss by curbing appetite and ...The FDA last year approved semaglutide, which was developed initially as a treatment for type 2 diabetes, for weight loss in adults. But researchers wanted to know if the drug, which targets areas ...Jun 20, 2022 · FDA approves potential game-changer drug for weight loss, but it comes with a hefty price tag 03:55 Nor does Leider view the weight loss products available without a prescription as competitors. A new prescription medication is dominating a weight loss market crowded with pills, powders, cleanses, juices, and more. In June of 2021, the FDA approved Wegovy (semaglutide), a weekly injectible.Apr 5, 2023 · The FDA approved Wegovy in June of 2021, marking the first time since 2014 that federal health authorities had given the green light to a new weight loss drug. (Low Wong’s views do not represent those of the FDA or the FDA Endocrinologic and Metabolic Drugs Advisory Committee .) The Food and Drug Administration approved Wegovy, a higher-dose version of Novo Nordisk's diabetes drug semaglutide, for long-term weight management. In company-funded studies, participants...Today, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one... A 'game-changer' weight-loss drug was approved in 2021. Demand was so high that there were shortages within months. Semaglutide, a weight-loss drug, showed promise for treating obesity in recent research. Demand quickly exceeded supply after the FDA in June approved once-weekly semaglutide injections. However, some experts worry that we don't ... Mar 12, 2022 · Alli is a 60-milligram, over-the-counter version of orlistat (Xenical), a 120-milligram prescription drug. Both Alli and Xenical are meant to be used as part of a weight-loss plan, along with a low-calorie, low-fat diet and regular physical activity. Alli is approved by the U.S. Food and Drug Administration for use in adults 18 and older who ... Jun 7, 2021 · In fact, Wegovy is the first weight-management drug that the FDA has approved for obesity since 2014. The FDA has now granted Novo Nordisk approval to market Wegovy specifically for adults with ... Jun 4, 2021 · Regulators on Friday said a new version of a popular diabetes medicine could be sold as a weight-loss drug in the U.S. The Food and Drug Administration approved Wegovy, a higher-dose version of ... Phentermine by itself (Adipex-P, Lomaira) also is used for weight loss. It's one of four similar weight-loss drugs approved for use for less than 12 weeks, called short-term use. The other drugs in this group aren't often prescribed. Semaglutide. Semaglutide also is used to help control type 2 diabetes. You take it as a weekly shot to manage ...What to know about Mounjaro, the next game-changing medication awaiting FDA approval to treat weight loss. Tirzepatide, a medication approved to treat diabetes, helps aid weight loss by lowering appetite. A similar drug called semaglutide was approved for obesity and became so popular it caused shortages. The FDA last year approved semaglutide, which was developed initially as a treatment for type 2 diabetes, for weight loss in adults. But researchers wanted to know if the drug, which targets areas ...Jan 3, 2023 · Diabetes drug Tirzepatide, which is shown to be more effective than Wegovy and Ozempic, is likely to be approved by the Food and Drug Administration for weight loss in 2023 and is expected to be ... Eli Lilly ( LLY -0.05%) recently told investors great news regarding its experimental diabetes drug, tirzepatide. Results from a big head-to-head study with Novo Nordisk 's ( NVO 2.72%) competing ...The FDA on Friday approved a new weight-loss drug, Wegovy, for people who are either obese or overweight and have at least one weight-related medical problem.Nov 10, 2022 · The FDA last year approved semaglutide, which was developed initially as a treatment for type 2 diabetes, for weight loss in adults. But researchers wanted to know if the drug, which targets areas ... Jun 20, 2023 · 6/15/2023. To treat diffuse large B-cell lymphoma, not otherwise specified, or large B-cell lymphoma arising from follicular lymphoma after two or more lines of systemic therapy. 22. Inpefa ... FDA approves weight-management drug Qsymia. Medications Target Long-Term Weight Control. FDA approves Belviq to treat some overweight or obese adults. Fen-Phen Safety Update Information.Phentermine by itself (Adipex-P, Lomaira) also is used for weight loss. It's one of four similar weight-loss drugs approved for use for less than 12 weeks, called short-term use. The other drugs in this group aren't often prescribed. Semaglutide. Semaglutide also is used to help control type 2 diabetes. You take it as a weekly shot to manage ...Nov 7, 2022 · The FDA has approved the drug Wegovy (semaglutide) treat obesity in children. The news comes after a study found that the weight loss drug may help adolescents significantly reduce BMI. It works ... Nov 10, 2022 · The FDA last year approved semaglutide, which was developed initially as a treatment for type 2 diabetes, for weight loss in adults. But researchers wanted to know if the drug, which targets areas ... A new weight loss drug could be the most effective drug available, though it won't be available for several years. Lilly's retatrutide led to 58 pounds of weight loss. ... While FDA approval of ...Alli: A Lower-Dose, OTC Version of Prescription Xenical. Alli ( orlistat ): is the over-the-counter (OTC) version of the FDA-approved prescription drug Xenical but it comes in a lower 60 milligram (mg) strength. is used in adults in conjunction with diet and regular exercise to promote weight loss.And yes, these drugs often come with the bonus side effect of weight loss. With most GLP-1 drugs, however, weight loss tends to be modest — most people lose only 6 to 9 pounds. Those who take 2.4 mg of semaglutide (Wegovy) often lose far more. If your starting weight is 200 pounds and the drug enables you to drop 15 percent, you'll lose 30 ...Jun 17, 2022 · By Simon On June 17, 2022. Eli Lilly’s new drug named, Mounjaro, is currently trending as it was recently approved by the FDA. Reports suggest that the people lost 50 pounds on average with a proper diet and increased physical activity during its trial phase. It costs around $974.33 for four weekly doses and many people believe its price is ... Phentermine by itself (Adipex-P, Lomaira) also is used for weight loss. It's one of four similar weight-loss drugs approved for use for less than 12 weeks, called short-term use. The other drugs in this group aren't often prescribed. Semaglutide. Semaglutide also is used to help control type 2 diabetes. You take it as a weekly shot to manage ...
Jun 11, 2021 · And yes, these drugs often come with the bonus side effect of weight loss. With most GLP-1 drugs, however, weight loss tends to be modest — most people lose only 6 to 9 pounds. Those who take 2.4 mg of semaglutide (Wegovy) often lose far more. If your starting weight is 200 pounds and the drug enables you to drop 15 percent, you'll lose 30 ... . Wink news live cameras
Sep 10, 2021 · On June 4, 2021, the FDA announced the long-anticipated approval of Wegovy, an injectable medication taken once per week for weight management.. Wegovy received significant media attention in the months preceding approval, with a New York Times article declaring it a "game changer," MedPage Today reporting its "unprecedented results," and the BBC announcing it could mark a "new era" in ... Jan 12, 2023 · 4. Orlistat. Orlistat (Xenical) is another brand-name prescription weight loss pill. It’s an oral capsule that adults can take 3 times per day with meals. However, it’s less common than other weight loss pills, it’s not approved for kids or adolescents, and it can cause some bothersome side effects. Alli is a 60-milligram, over-the-counter version of orlistat (Xenical), a 120-milligram prescription drug. Both Alli and Xenical are meant to be used as part of a weight-loss plan, along with a low-calorie, low-fat diet and regular physical activity. Alli is approved by the U.S. Food and Drug Administration for use in adults 18 and older who ...Alli is a 60-milligram, over-the-counter version of orlistat (Xenical), a 120-milligram prescription drug. Both Alli and Xenical are meant to be used as part of a weight-loss plan, along with a low-calorie, low-fat diet and regular physical activity. Alli is approved by the U.S. Food and Drug Administration for use in adults 18 and older who ...A clinical trial found that a high dose of tirzepatide helped patients lose about 52 pounds, or an average of 22.5% of their body weight. Tirzepatide, when approved by the FDA, is predicted to hit ...Mar 21, 2023 · Food and Drug Administration. FDA approves new drug treatment for chronic weight management, first since 2014. National Library of Medicine: DailyMed. Wegovy—semaglutide injection, solution [drug label]. National Library of Medicine: DailyMed. Mounjaro—tirzepatide injection, solution [drug label]. Jun 7, 2022 · An under-the-skin injection that showed promise in weight-loss clinical trials is now fully approved for certain obese or overweight Americans. The U.S. Food and Drug Administration on Friday ... Apr 27, 2023 · Eli Lilly seeks FDA approval for weight loss drug tirzepatide 01:57. As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare ... Mar 2, 2022 · Last year, the U.S. Food and Drug Administration (FDA) approved Wegovy (semaglutide) for chronic weight management in adults with obesity or who are overweight and have at least one weight-related condition (such as diabetes or hypertension). This is the first weight loss drug approval from the FDA since 2014. New weight loss drug is a game-changer Jun 27, 2012 · June 27, 2012. 0. WASHINGTON (AP) -- The Food and Drug Administration has approved Arena Pharmaceutical's anti-obesity pill Belviq, the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade. Despite only achieving modest weight loss in clinical studies, the drug appeared safe enough to win the FDA's ... Aug 14, 2023 · Xenical (Orlistat) Alli (Orlistat) Contrave (Bupropion-Naltrexone) Saxenda (Liraglutide) Qsymia (Phentermine-Topiramate) For people with obesity, weight loss is often a difficult journey that requires lifestyle changes. Sometimes, when dietary changes and exercise are not enough, your healthcare provider may prescribe a weight loss medication. Jun 7, 2021 · The new drug, Wegovy, has proven to be safer and more effective than existing weight loss drugs, says MSN. Wegovy is approved and intended for obese and overweight adults, reported Science Alert. The drug is expected to hit consumer markets in the U.S. very soon, according to MSN. The price has not yet been confirmed but is expected to cost ... The Food and Drug Administration (FDA) issued a rare approval for a new weight loss device this week. Plenity, created by Boston biotech company Gelesis, is a hydrogel capsule made with a ...Jun 27, 2022 · FDA approved Qsymia in July 2012 for chronic weight management in adults with an initial BMI of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one ... Jun 20, 2023 · 6/15/2023. To treat diffuse large B-cell lymphoma, not otherwise specified, or large B-cell lymphoma arising from follicular lymphoma after two or more lines of systemic therapy. 22. Inpefa ... Jan 1, 2023 · In 2023, the FDA will likely approve Eli Lilly's diabetes drug tirzepatide for weight loss — but there's little indication insurers will widely cover the medication. A new class of... .